Marcus Joel S
Officer at ARE; Director at ITCI; Director at KRRO, and 3 more
- Sold, on record
- $172M
- Dollars the filings state
- Form 4 sales
- 154
- Latest Feb 26, 2024
- Form 144 notices
- 3
- Proposed sales
- Companies
- 6
- Filed as an executive or holder
Companies
Sales by reason
0
Routine
131
Plan not stated
2
No plan
21
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- ARE1.4M shares
- ITCI306,466 shares
- ATRA92,590 shares
- KRRO82,509 shares
- Applied Therapeutics, Inc.40,000 shares
- MGTX20,381 shares
Shares sold, every Form 4 sale on record.
Timeline
- Feb 26, 2024No plan
Sold 1.7% of their holdings
$892k7,500 shares at $118.92
- Feb 26, 2024Unusual
Sold 39.9% of their holdings
$1.8M26,328 shares at $68.68
- Feb 26, 2024Notice
Filed a notice to sell 26,328 shares
$1.8M26,328 shares
- Feb 26, 2024Notice
Filed a notice to sell 7,500 shares
$899k7,500 shares
- May 8, 2023No plan
Sold 2.1% of their holdings
$917k7,500 shares at $122.20
- May 8, 2023Notice
Filed a notice to sell 9,500 shares
$1.2M9,500 shares
- Feb 7, 2023Plan not stated
Sold 2.3% of their holdings
$1.5M9,000 shares at $168.00
- Dec 19, 2022Plan not stated
Sold 14.6% of their holdings
$254k5,000 shares at $50.82
- Dec 12, 2022Plan not stated
Sold 1.9% of their holdings
$975k6,500 shares at $150.00
- Dec 5, 2022Plan not stated
Sold 0.7% of their holdings
$380k2,500 shares at $152.00
10 of 157
Every transaction
Loading transactions…
Sales and notices (157)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | Feb 28, 2024 | ARE | Executive Chairman | Form 4 sale | 7,500 | $892k | 1.7% | No plan | SEC |
| Feb 26, 2024 | Feb 27, 2024 | ITCI | Director | Form 4 sale | 26,328 | $1.8M | 39.9% | Unusual | SEC |
| Feb 26, 2024 | Feb 26, 2024 | ITCI | Director | Form 144 notice | 26,328 | $1.8M | Notice | SEC | |
| Feb 26, 2024 | Feb 26, 2024 | ARE | Officer | Form 144 notice | 7,500 | $899k | Notice | SEC | |
| May 8, 2023 | May 10, 2023 | ARE | Executive Chairman | Form 4 sale | 7,500 | $917k | 2.1% | No plan | SEC |
| May 8, 2023 | May 8, 2023 | ARE | Officer | Form 144 notice | 9,500 | $1.2M | Notice | SEC | |
| Feb 7, 2023 | Feb 9, 2023 | ARE | Executive Chairman | Form 4 sale | 9,000 | $1.5M | 2.3% | Plan not stated | SEC |
| Dec 19, 2022 | Dec 21, 2022 | ITCI | Director | Form 4 sale | 5,000 | $254k | 14.6% | Plan not stated | SEC |
| Dec 12, 2022 | Dec 14, 2022 | ARE | Executive Chairman | Form 4 sale | 6,500 | $975k | 1.9% | Plan not stated | SEC |
| Dec 5, 2022 | Dec 7, 2022 | ARE | Executive Chairman | Form 4 sale | 2,500 | $380k | 0.7% | Plan not stated | SEC |
| Nov 7, 2022 | Nov 8, 2022 | ITCI | Director | Form 4 sale | 10,000 | $523k | 22.6% | Plan not stated | SEC |
| Aug 11, 2022 | Aug 12, 2022 | ITCI | Director | Form 4 sale | 10,000 | $592k | 18.4% | Plan not stated | SEC |
| May 12, 2022 | May 13, 2022 | ITCI | Director | Form 4 sale | 10,000 | $550k | 15.6% | Plan not stated | SEC |
| Mar 8, 2022 | Mar 9, 2022 | ITCI | Director | Form 4 sale | 20,000 | $1.1M | 40.8% | Unusual | SEC |
| Aug 9, 2021 | Aug 11, 2021 | ARE | Executive Chairman | Form 4 sale | 7,500 | $1.6M | 2.4% | Plan not stated | SEC |
| Aug 2, 2021 | Aug 4, 2021 | ARE | Executive Chairman | Form 4 sale | 5,000 | $1M | 1.6% | Plan not stated | SEC |
| Jul 29, 2021 | Jul 30, 2021 | ARE | Executive Chairman | Form 4 sale | 20,000 | $4M | 6.0% | Plan not stated | SEC |
| Jun 14, 2021 | Jun 15, 2021 | ITCI | Director | Form 4 sale | 18,289 | $773k | 27.2% | Unusual | SEC |
| May 4, 2021 | May 5, 2021 | ARE | Executive Chairman | Form 4 sale | 20,000 | $3.6M | 5.6% | Plan not stated | SEC |
| Mar 2, 2021 | Mar 4, 2021 | ITCI | Director | Form 4 sale | 15,250 | $533k | 17.4% | Plan not stated | SEC |
| Dec 22, 2020 | Dec 22, 2020 | KRRO | Director | Form 4 sale | 49,700 | $1.7M | 15.5% | Plan not stated | SEC |
| Aug 17, 2020 | Aug 19, 2020 | ARE | Executive Chairman | Form 4 sale | 7,500 | $1.3M | 2.3% | Plan not stated | SEC |
| Aug 12, 2020 | Aug 12, 2020 | MGTX | Director | Form 4 sale | 15,459 | $217k | 100.0% | Unusual | SEC |
| Aug 3, 2020 | Aug 4, 2020 | ARE | Executive Chairman | Form 4 sale | 45,000 | $7.9M | 11.9% | Unusual | SEC |
| Jun 5, 2020 | Jun 9, 2020 | ARE | Executive Chairman | Form 4 sale | 25,000 | $3.9M | 6.2% | Plan not stated | SEC |
| May 21, 2020 | May 22, 2020 | KRRO | Director | Form 4 sale | 5,000 | $94k | 1.5% | Plan not stated | SEC |
| May 20, 2020 | May 20, 2020 | KRRO | Director | Form 4 sale | 27,809 | $525k | 7.9% | Plan not stated | SEC |
| May 15, 2020 | May 15, 2020 | Applied Therapeutics, Inc. | Director | Form 4 sale | 40,000 | $1.8M | 9.9% | Plan not stated | SEC |
| May 14, 2020 | May 15, 2020 | ITCI | Director | Form 4 sale | 9,602 | $192k | 19.7% | Plan not stated | SEC |
| May 13, 2020 | May 13, 2020 | ITCI | Director | Form 4 sale | 57,297 | $1.1M | 79.9% | Unusual | SEC |
| May 12, 2020 | May 14, 2020 | MGTX | Director | Form 4 sale | 4,922 | $78k | 6.2% | Plan not stated | SEC |
| May 5, 2020 | May 7, 2020 | ARE | Executive Chairman | Form 4 sale | 25,000 | $3.8M | 5.9% | Plan not stated | SEC |
| Apr 30, 2020 | May 4, 2020 | ARE | Executive Chairman | Form 4 sale | 10,000 | $1.6M | 2.3% | Plan not stated | SEC |
| Feb 12, 2020 | Feb 14, 2020 | ARE | Executive Chairman | Form 4 sale | 35,000 | $6.1M | 7.6% | Unusual | SEC |
| Sep 27, 2019 | Oct 1, 2019 | ARE | Executive Chairman | Form 4 sale | 7,500 | $1.2M | 1.7% | Plan not stated | SEC |
| Sep 6, 2019 | Sep 10, 2019 | ARE | Executive Chairman | Form 4 sale | 9,750 | $1.5M | 2.1% | Plan not stated | SEC |
| Aug 9, 2019 | Aug 12, 2019 | ARE | Executive Chairman | Form 4 sale | 25,000 | $3.6M | 5.2% | Plan not stated | SEC |
| Aug 2, 2019 | Aug 5, 2019 | ARE | Executive Chairman | Form 4 sale | 20,000 | $2.9M | 4.0% | Plan not stated | SEC |
| May 8, 2019 | May 10, 2019 | ARE | Executive Chairman | Form 4 sale | 8,500 | $1.2M | 1.7% | Plan not stated | SEC |
| May 2, 2019 | May 6, 2019 | ARE | Executive Chairman | Form 4 sale | 15,000 | $2.1M | 2.9% | Plan not stated | SEC |
| Mar 28, 2019 | Mar 29, 2019 | ARE | Executive Chairman | Form 4 sale | 45,000 | $6.4M | 8.2% | Unusual | SEC |
| Mar 15, 2019 | Mar 19, 2019 | ATRA | Director | Form 4 sale | 20,000 | $765k | 2.2% | Plan not stated | SEC |
| Feb 28, 2019 | Mar 1, 2019 | ATRA | Director | Form 4 sale | 62,590 | $2.3M | 89.3% | Unusual | SEC |
| Feb 15, 2019 | Feb 20, 2019 | ARE | Executive Chairman | Form 4 sale | 10,000 | $1.3M | 1.8% | Plan not stated | SEC |
| Feb 7, 2019 | Feb 11, 2019 | ARE | Executive Chairman | Form 4 sale | 10,000 | $1.3M | 1.8% | Plan not stated | SEC |
| Dec 11, 2018 | Dec 13, 2018 | ARE | Executive Chairman | Form 4 sale | 10,000 | $1.3M | 1.8% | Plan not stated | SEC |
| Dec 3, 2018 | Dec 4, 2018 | ARE | Executive Chairman | Form 4 sale | 10,000 | $1.2M | 1.8% | Plan not stated | SEC |
| Nov 12, 2018 | Nov 13, 2018 | ITCI | Director | Form 4 sale | 32,000 | $582k | 28.9% | Unusual | SEC |
| Nov 7, 2018 | Nov 8, 2018 | ATRA | Director | Form 4 sale | 10,000 | $364k | 56.9% | Unusual | SEC |
| Nov 6, 2018 | Nov 8, 2018 | ARE | Executive Chairman | Form 4 sale | 5,000 | $614k | 0.9% | Plan not stated | SEC |
Showing the first 50